| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |